England subsidises drugs like Ozempic for weight loss. Could Australia follow?
- Written by Jonathan Karnon, Professor of Health Economics, Flinders University

People with a high body weight living in England can now access subsidised weight-loss drugs to treat their obesity. This includes Wegovy (the weight-loss dose of Ozempic, or semaglutide) and Mounjaro (one of the brand names for tirzepatide).
These drugs, known as GLP-1 agonists, can improve the health of people who are...
Read more: England subsidises drugs like Ozempic for weight loss. Could Australia follow?